Androgen receptor in triple negative breast cancer: A potential target for the targetless subtypeLorenzo Gerratana, Grazia Arpino, Debora Basile et al.|Cancer Treatment Reviews|2018Cited by 282
Health-related quality of life in breast cancer patients treated with CDK4/6 inhibitors: a systematic reviewVincenzo Di Lauro, Michelino De Laurentiis, Caterina Fontanella et al.|ESMO Open|2022Cited by 40
Bridging the Gap: the role of MDM2 inhibition in overcoming treatment resistance in breast cancerG Grazia, Federica Martorana, Chiara Conti et al.|Critical Reviews in Oncology/Hematology|2025Cited by 5
REThinking the role of the RET oncogene in breast cancerG Grazia, Paolo Vigneri, Chiara Conti et al.|Frontiers in Oncology|2024Cited by 3